Geneva, April 28 -- International Clinical Trials Registry received information related to the study (KCT0011836) titled 'Study of glofitamab in combination with ifosfamide, carboplatin, and etoposide (G-ICE) in relapsed/refractory diffuse large B-cell lymphoma patients' on April 13.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Single Group, Blinding/Masking : Open, Allocation : Non-RCT
Primary Sponsor: Asan Medical Center
Condition:
Neoplasms
Intervention:
Drug : 1. Initial treatment
All patients will receive 3 cycles of glofitamab + ICE
2. Interim response assessment and treatment allocation
- Interim response assessment with PET/CT and MRD will be conducted after Cycle 2
- ...